Trelleborg
Trelleborg invests in new healthcare & medical facility in Costa Rica
Trelleborg has decided to invest in a new production facility in Costa Rica for medical technology solutions. The new facility will be established close to a number of international customers with operations in the region. On completion, the facility will offer a full product suite of engineered polymer solutions within healthcare & medical.
Covering an area of 10,000 square meters, the production facility will be Trelleborg’s first in Central America and is expected to be completed in 2025. The Group will invest approximately SEK 225 M in total between 2024 and 2025.
“Costa Rica has evolved into a medical technology hub in Central America and the facility therefore represents an important step in both increasing our capacity and broadening our geographical footprint in healthcare & medical. The facility is being built for customers with global sales, and the capacity it will add will also benefit Baron Group, the Australian-Chinese company we recently signed an agreement to acquire. Trelleborg’s know-how combined with Baron’s technology will provide the basis for the new facility,” says Peter Nilsson, President and CEO of Trelleborg.
The state-of-the-art facility is being built in the city of Grecia, close to the port and an international airport, and a half-hour drive from the main cities in western Costa Rica. It will feature cleanroom production and be designed to meet stringent industry-specific standards for medical device manufacturing, as well as ensuring efficient and sustainable production processes. Sustainability will permeate the building, which will be Leadership in Energy & Environmental Design (LEED) certified.
Datum | 2024-02-06, kl 14:30 |
Källa | MFN |
![](https://static.allaaktier.se/ads/hand-waving-2.png)